Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
[Spasticity and everyday life in multiple sclerosis].
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Hatha Yoga and Executive Function: A Systematic Review.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.
Vm24, a Natural Immunosuppressant Peptide Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells.
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
Cognitive rehabilitation in Multiple sclerosis.
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Brain circuitry outside the synaptic cleft.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
Managed care aspects of managing multiple sclerosis.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
262
263
264
265
266
267
268
269
270
…
next ›
last »